It was documented that inhibition of the Shh pathway could silence the activity of GLI1/2/38,9 and thereby induced caspase-dependent apoptosis and growth inhibition in non-Hodgkin lymphoma cells and chronic myeloid leukemia cells10,11. This evidence concerns the gene GLI1 and chronic myelogenous leukemia, BCR-ABL1 positive.